INSM Stock News & Analysis | Latest Updates

Insmed (NASDAQ:INSM) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Insmed (INSM) Conference Call Follow this link to access the live webcast.

April 28, 2022

INSM News

Insmed shares are trading lower after the company reported Q4 financial results and missed its EPS estimate.

Insmed Continues To Anticipate Full-year 2025 Global Arikayce Revenues In The Range Of $405M-$425M, Representing Between 11% And 17% Year-over-year Growth Compared To 2024

Insmed Q4 2024 GAAP EPS $(1.32) Misses $(1.17) Estimate, Sales $104.44M Beat $101.79M Estimate

Cantor Fitzgerald Reiterates Overweight on Insmedto Overweight

Wells Fargo Maintains Overweight on Insmed, Raises Price Target to $107

Here's How Much $100 Invested In Insmed 10 Years Ago Would Be Worth Today

Peering Into Insmed's Recent Short Interest

How Is The Market Feeling About Insmed?

Insmed Provides Outlook Ahead Of J.P. Morgan Healthcare Conference; Sees 2025 Global ARIKAYCE Revenues $405M-$425M

Insmed On Nov. 18 Terminated Sales Agreement With Leerink Partners

Insmed's Options: A Look at What the Big Money is Thinking

Truist Securities Reiterates Buy on Insmed, Raises Price Target to $105

HC Wainwright & Co. Reiterates Buy on Insmed, Maintains $90 Price Target

Insmed Reiterates Its Guidance For Full-year 2024 Global Arikayce Revenues Of $340M-$360M

Insmed Q3 2024 GAAP EPS $(1.27) Misses $(1.21) Estimate, Sales $93.42M Beat $93.01M Estimate

Insmed Presents Patient-Reported Outcomes And Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE In Patients With NTM Lung Disease Caused By MAC At American Thoracic Society 2024 International Conference Plenary Session

Truist Securities Maintains Buy on Insmed, Maintains $48 Price Target

How To Attend Insmed Q1 2022 Earnings Conference Call